SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-04-135972
Filing Date
2004-08-09
Accepted
2004-08-09 16:42:46
Documents
3
Period of Report
2004-08-09
Items
Item 12: Results of Operations and Financial Condition
Item 5: Other events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 11836
2 PRESS RELEASE ANNOUNCING THE COMPANY'S AGREEMENT dex991.htm EX-99.1 11972
3 PRESS RELEASE ANNOUNCING THE COMPANY'S 2004 SECOND QUARTER RESULTS dex992.htm EX-99.2 74653
  Complete submission text file 0001193125-04-135972.txt   100257
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 04961866
SIC: 2836 Biological Products, (No Diagnostic Substances)